Taylor Financial Group Inc. Sells 600 Shares of Danaher Corporation $DHR

Taylor Financial Group Inc. reduced its stake in shares of Danaher Corporation (NYSE:DHR) by 16.3% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 3,090 shares of the conglomerate’s stock after selling 600 shares during the period. Taylor Financial Group Inc.’s holdings in Danaher were worth $610,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in DHR. Nuveen LLC bought a new stake in shares of Danaher during the first quarter worth $833,941,000. Invesco Ltd. boosted its stake in Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the period. Baird Financial Group Inc. lifted its holdings in shares of Danaher by 290.6% in the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock valued at $295,550,000 after purchasing an additional 1,072,617 shares in the last quarter. Generation Investment Management LLP lifted its holdings in shares of Danaher by 33.2% in the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock valued at $651,515,000 after purchasing an additional 791,662 shares in the last quarter. Finally, Parnassus Investments LLC lifted its holdings in shares of Danaher by 23.3% in the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock valued at $784,745,000 after purchasing an additional 722,636 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.8%

Danaher stock opened at $221.20 on Tuesday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The stock has a market capitalization of $156.24 billion, a P/E ratio of 45.61, a PEG ratio of 3.41 and a beta of 0.77. The stock has a 50-day simple moving average of $202.97 and a 200 day simple moving average of $198.77. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period last year, the firm posted $1.71 earnings per share. The business’s revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is currently 26.39%.

Analyst Ratings Changes

A number of brokerages recently issued reports on DHR. UBS Group dropped their target price on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Wells Fargo & Company reaffirmed a “positive” rating on shares of Danaher in a research note on Thursday. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Rothschild & Co Redburn restated a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Finally, Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.